IP Verse

Merial competitive analysis

Latest publications and patents of Merial New

Explore the latest publications and patents granted to Merial, showcasing their recent innovations and technological advancements.

Last updated on: Sep 30, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Merial

EP2785374
Aug 17, 2022Recombinant Gallid Herpesvirus 3 (Mdv Serotype 2) Vectors Expressing Antigens Of Avian Pathogens And Uses ThereofPatent Maintained As Amended
EP2998315
Nov 3, 2021Newcastle Disease Virus Vectored Avian VaccinesPatent Maintained As Amended
EP3061454
Mar 10, 2021Parasiticidal Oral Veterinary Compositions Comprising Systemically-Acting Active Agents, Methods And Uses ThereofRevoked
EP3167900
Nov 21, 2018Vaccine Against StreptococciRevoked
EP2944322
Jan 17, 2018Bluetongue Virus Recombinant Vaccines And Uses ThereofNo Opposition Filed Within Time Limit
EP2874653
Dec 27, 2017Method Of Providing Protective Immunity Against Heterologous Leptospira StrainsOpposition Rejected

Latest patents of Merial opposed by its competitors

Explore Merial's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2785374
Aug 17, 2022Recombinant Gallid Herpesvirus 3 (Mdv Serotype 2) Vectors Expressing Antigens Of Avian Pathogens And Uses Thereof1
EP2998315
Nov 3, 2021Newcastle Disease Virus Vectored Avian Vaccines1
EP3061454
Mar 10, 2021Parasiticidal Oral Veterinary Compositions Comprising Systemically-Acting Active Agents, Methods And Uses Thereof2
EP3167900
Nov 21, 2018Vaccine Against Streptococci1
EP2874653
Dec 27, 2017Method Of Providing Protective Immunity Against Heterologous Leptospira Strains1

Latest PTAB cases involving Merial

Discover the latest PTAB cases involving Merial, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 6, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Merial

IPR2018-00919Apr 13, 2018MERIALINTERVETInstitution Denied
IPR2016-01182Jun 10, 2016MERIALFIDOPHARMTerminated-Settled
IPR2016-00798Mar 25, 2016MERIALSERGEANTS PET CARE PRODUCTSInstitution Denied
IPR2015-00254Nov 10, 2014BIOMUNEMERIALFinal Written Decision
IPR2014-01279Aug 14, 2014MERIALVIRBACFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Merial with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
MERIAL - 641Balanced
BIOMUNE - - 1 - Highly Aggressive
FIDOPHARM - - - 1Non-Active
INTERVET113441Balanced